🇺🇸 FDA
Patent

US 9828373

2-amino-pyrido[2,3-D]pyrimidin-7(8H)-one derivatives as CDK inhibitors and uses thereof

granted A61KA61K31/519A61K31/5377

Quick answer

US patent 9828373 (2-amino-pyrido[2,3-D]pyrimidin-7(8H)-one derivatives as CDK inhibitors and uses thereof) held by SUNSHINE LAKE PHARMA CO., LTD. expires Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SUNSHINE LAKE PHARMA CO., LTD.
Grant date
Tue Nov 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/519, A61K31/5377, A61K31/5383, A61K45/06